tskgel superq-spw (Tosoh Corporation)
90
Structured Review
Tosoh Corporation
tskgel superq-spw
Tskgel Superq Spw, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spw/tskgel+superq+5pw+column/us12364769-2018-3-1
Average 90 stars, based on 1 article reviews
Tskgel Superq Spw, supplied by Tosoh Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spw/tskgel+superq+5pw+column/us12364769-2018-3-1
Average 90 stars, based on 1 article reviews
tskgel superq-spw - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Purification:Article Title: Modified RNA agents with reduced off-target effect Article Snippet: The longmers were desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), eluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Article Title: Nucleic acid-polypeptide compositions and uses thereof Article Snippet: Column: Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Anion Exchange Chromatography Method SAX-1 Column: Article Title: Modified RNA agents with reduced off-target effect Article Snippet: All single strands were purified to >85% HPLC (260 nm) purity and then desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), eluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Article Title: Modified RNA agents with reduced off-target effect Article Snippet: All single strands were purified to >85% HPLC (260 nm) purity and then desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), cluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: High Performance Liquid Chromatography:Article Title: Modified RNA agents with reduced off-target effect Article Snippet: The longmers were desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), eluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Article Title: Nucleic acid-polypeptide compositions and uses thereof Article Snippet: Column: Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Anion Exchange Chromatography Method SAX-1 Column: Article Title: Modified RNA agents with reduced off-target effect Article Snippet: All single strands were purified to >85% HPLC (260 nm) purity and then desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), eluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Article Title: Modified RNA agents with reduced off-target effect Article Snippet: All single strands were purified to >85% HPLC (260 nm) purity and then desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), cluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Solvent:Article Title: Modified RNA agents with reduced off-target effect Article Snippet: The longmers were desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), eluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Article Title: Nucleic acid-polypeptide compositions and uses thereof Article Snippet: Column: Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Anion Exchange Chromatography Method SAX-1 Column: Article Title: Modified RNA agents with reduced off-target effect Article Snippet: All single strands were purified to >85% HPLC (260 nm) purity and then desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), eluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Article Title: Modified RNA agents with reduced off-target effect Article Snippet: All single strands were purified to >85% HPLC (260 nm) purity and then desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), cluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Chromatography:Article Title: Modified RNA agents with reduced off-target effect Article Snippet: The longmers were desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), eluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Article Title: Nucleic acid-polypeptide compositions and uses thereof Article Snippet: Column: Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Anion Exchange Chromatography Method SAX-1 Column: Article Title: Modified RNA agents with reduced off-target effect Article Snippet: All single strands were purified to >85% HPLC (260 nm) purity and then desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), eluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: Article Title: Modified RNA agents with reduced off-target effect Article Snippet: All single strands were purified to >85% HPLC (260 nm) purity and then desalted by size exclusion chromatography on an AKTA Prime chromatography system using an AP-2 glass column (20×300 mm, Waters) custom-packed with Sephadex G25 (GE Healthcare), cluted with sterile nuclease-free water. Article Title: Compositions and methods of treating muscle atrophy and myotonic dystrophy Article Snippet: Column: |